Jubbin Jagan Jacob
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Jubbin Jagan Jacob has a total of 119 co-authors. Here are the top co-authors by number of shared publications:
Nihal Thomas
Department of Endocrinology, Christian Medical College and Hospital, Vellore, Tamil Nadu, India
8 shared publications- Nihal Thomas
Department of Endocrinology, Diabetes and Metabolism, Christian Medical College Vellore, Vellore, India
5 shared publications Sandeep Chopra
1lDepartment of Cardiology, Christian Medical College, Ludhiana, Punjab, India
5 shared publicationsAravindan Nair
Department of Surgical Endocrinology Christian Medical College and Hospital 632004 Vellore India
4 shared publicationsSanjay Kalra
Department of Endocrinology, Bharti Hospital, Karnal, Haryana, India
4 shared publicationsBen Selvan
Department of Surgical Endocrinology Christian Medical College and Hospital 632004 Vellore India
3 shared publications
Latest Publications
- Open Access
- 23 October 2025
- Published by IntechOpen
Adrenal Insufficiency Associated with Inhaled Corticosteroid Use
Inhaled corticosteroids (ICS) are the first-line treatment for persistent asthma and chronic respiratory diseases due to their strong local anti-inflammatory effects and better safety profile compared to systemic corticosteroids. However, their use for a long period, especially at higher doses or together with other corticosteroid products, can lead to suppression of the hypothalamic-pituitary-adrenal (HPA) axis and cause secondary adrenal insufficiency. This is not a well-known clinical problem because of its gradual onset and nonspecific symptoms, but it can lead to serious health issues such as adrenal crisis during physiological stress. This chapter encapsulates all aspects of adrenal insufficiency associated with inhaled corticosteroids, starting with HPA axis physiology and ICS pharmacokinetics and pharmacodynamics. The chapter describes the current algorithms for pathophysiology, clinical presentation, the diagnostic approach, and ICS-induced adrenal insufficiency along with management strategies that are based on the latest clinical guidelines. There is strong focus on the risk stratification, recommended regular monitoring, and prevention strategies to minimize HPA axis suppression due to ICS. The clinical applications of these topics are clearly depicted in algorithms, tables, and infographics to maximize the reader’s comprehension. Due to the prevalent usage of inhaled corticosteroids in both adults and pediatric population for the management of various obstructive respiratory illnesses, it is crucial to identify and proactively manage adrenal insufficiency to ensure patient safety while not compromising on controlling the disease.
- 23 October 2025
- Published by IntechOpen
Open AccessAdrenal Insufficiency Associated with Inhaled Corticosteroid Use
Inhaled corticosteroids (ICS) are the first-line treatment for persistent asthma and chronic respiratory diseases due to their strong local anti-inflammatory effects and better safety profile compared to systemic corticosteroids. However, their use for a long period, especially at higher doses or together with other corticosteroid products, can lead to suppression of the hypothalamic-pituitary-adrenal (HPA) axis and cause secondary adrenal insufficiency. This is not a well-known clinical problem because of its gradual onset and nonspecific symptoms, but it can lead to serious health issues such as adrenal crisis during physiological stress. This chapter encapsulates all aspects of adrenal insufficiency associated with inhaled corticosteroids, starting with HPA axis physiology and ICS pharmacokinetics and pharmacodynamics. The chapter describes the current algorithms for pathophysiology, clinical presentation, the diagnostic approach, and ICS-induced adrenal insufficiency along with management strategies that are based on the latest clinical guidelines. There is strong focus on the risk stratification, recommended regular monitoring, and prevention strategies to minimize HPA axis suppression due to ICS. The clinical applications of these topics are clearly depicted in algorithms, tables, and infographics to maximize the reader’s comprehension. Due to the prevalent usage of inhaled corticosteroids in both adults and pediatric population for the management of various obstructive respiratory illnesses, it is crucial to identify and proactively manage adrenal insufficiency to ensure patient safety while not compromising on controlling the disease.
- Open Access
- 1 January 2025
- Published by Wolters Kluwer Health in Indian Journal of Endocrinology and Metabolism
- Vol. 29 (1) , 1-3
Diabetic Bone Disease – An Indian Snapshot
- 1 January 2025
- Published by Wolters Kluwer Health in Indian Journal of Endocrinology and Metabolism
- Vol. 29 (1) , 1-3
Open AccessDiabetic Bone Disease – An Indian Snapshot
- Open Access
- 1 September 2024
- Published by Wolters Kluwer Health in Indian Journal of Endocrinology and Metabolism
- Vol. 28 (5) , 433-435
Gut–Brain Hormone Analogues and Metabolic Magic Wand
- 1 September 2024
- Published by Wolters Kluwer Health in Indian Journal of Endocrinology and Metabolism
- Vol. 28 (5) , 433-435
Open AccessGut–Brain Hormone Analogues and Metabolic Magic Wand
- Open Access
- 1 March 2024
- Published by Medknow in Indian Journal of Endocrinology and Metabolism
- Vol. 28 (2) , 101-103
Tackling the Rising Tide: Understanding the Prevalence of Childhood Obesity in India
- 1 March 2024
- Published by Medknow in Indian Journal of Endocrinology and Metabolism
- Vol. 28 (2) , 101-103
Open AccessTackling the Rising Tide: Understanding the Prevalence of Childhood Obesity in India
- Open Access
- 22 February 2023
- Published by Hindawi Limited in International Journal of Endocrinology
- Vol. 2023, 1-10
Expert Opinion on the Diagnosis and Management of Male Hypogonadism in India
Male hypogonadism (MH) is a clinical and biochemical syndrome caused by inadequate synthesis of testosterone. Untreated MH can result in long-term effects, including metabolic, musculoskeletal, mood-related, and reproductive dysfunction. Among Indian men above 40years of age, the prevalence of MH is 2029. Among men with type 2 diabetes mellitus, 20.7 are found to have hypogonadism. However, due to suboptimal patient-physician communication, MH remains heavily underdiagnosed. For patients with confirmed hypogonadism (either primary or secondary testicular failure), testosterone replacement therapy (TRT) is recommended. Although various formulations exist, optimal TRT remains a considerable challenge as patients often need individually tailored therapeutic strategies. Other challenges include the absence of standardized guidelines on MH for the Indian population, inadequate physician education on MH diagnosis and referral to endocrinologists, and a lack of patient awareness of the long-term effects of MH in relation to comorbidities. Five nationwide advisory board meetings were convened to garner expert opinions on diagnosis, investigations, and available treatment options for MH, as well as the need for a person-centered approach. Experts opinions have been formulated into a consensus document with the aim of improving the screening, diagnosis, and therapy of men living with hypogonadism.
- 22 February 2023
- Published by Hindawi Limited in International Journal of Endocrinology
- Vol. 2023, 1-10
Open AccessExpert Opinion on the Diagnosis and Management of Male Hypogonadism in India
Male hypogonadism (MH) is a clinical and biochemical syndrome caused by inadequate synthesis of testosterone. Untreated MH can result in long-term effects, including metabolic, musculoskeletal, mood-related, and reproductive dysfunction. Among Indian men above 40years of age, the prevalence of MH is 2029. Among men with type 2 diabetes mellitus, 20.7 are found to have hypogonadism. However, due to suboptimal patient-physician communication, MH remains heavily underdiagnosed. For patients with confirmed hypogonadism (either primary or secondary testicular failure), testosterone replacement therapy (TRT) is recommended. Although various formulations exist, optimal TRT remains a considerable challenge as patients often need individually tailored therapeutic strategies. Other challenges include the absence of standardized guidelines on MH for the Indian population, inadequate physician education on MH diagnosis and referral to endocrinologists, and a lack of patient awareness of the long-term effects of MH in relation to comorbidities. Five nationwide advisory board meetings were convened to garner expert opinions on diagnosis, investigations, and available treatment options for MH, as well as the need for a person-centered approach. Experts opinions have been formulated into a consensus document with the aim of improving the screening, diagnosis, and therapy of men living with hypogonadism.
- Open Access
- 7 December 2022
- Published by Elsevier in Nefrología (English Edition)
- Vol. 44 (2) , 286-288
Prognostic implication of thyroid hormones among patients with acute kidney injury
- 7 December 2022
- Published by Elsevier in Nefrología (English Edition)
- Vol. 44 (2) , 286-288
Open AccessPrognostic implication of thyroid hormones among patients with acute kidney injury
- Open Access
- 1 November 2022
- Published by Medknow in Indian Journal of Endocrinology and Metabolism
- Vol. 26 (6) , 499-500
Management of Obesity: Finding the Metabolic Magic Wand
- 1 November 2022
- Published by Medknow in Indian Journal of Endocrinology and Metabolism
- Vol. 26 (6) , 499-500
Open AccessManagement of Obesity: Finding the Metabolic Magic Wand
- Open Access
- 4 August 2022
- Published by Medknow in Indian Journal of Endocrinology and Metabolism
- Vol. 26 (3) , 195-197
Glucocorticoid Use Audits
- 4 August 2022
- Published by Medknow in Indian Journal of Endocrinology and Metabolism
- Vol. 26 (3) , 195-197
Open AccessGlucocorticoid Use Audits
- Open Access
- 25 May 2022
- Published by Elsevier in Osteoporosis and Sarcopenia
- Vol. 8 (2) , 35-57
South Asian Working Action Group on SARCOpenia (SWAG-SARCO) – A consensus document
- 25 May 2022
- Published by Elsevier in Osteoporosis and Sarcopenia
- Vol. 8 (2) , 35-57
Open AccessSouth Asian Working Action Group on SARCOpenia (SWAG-SARCO) – A consensus document
- 18 February 2022
- Published by Springer Nature in Osteoporosis International
- Vol. 33 (6) , 1397-1399
Romosozumab and cardiovascular safety—should we learn lessons from pioglitazone?
- 18 February 2022
- Published by Springer Nature in Osteoporosis International
- Vol. 33 (6) , 1397-1399
Romosozumab and cardiovascular safety—should we learn lessons from pioglitazone?